diagnostics

Innovations in Research Methods and Reporting

Need for Percent Area Reduction and Percent Volume Reduction Measurements in Diagnostic Wound Imaging: A Statement From the Wound Care Collaborative Community—Part 1

03/01/2024

Alisha Oropallo

Peggy Dotson

Tod Brindle

Vickie R Driver

Lisa Gould

03/01/2024

Wounds

Research Reports

Enhancing Multidisciplinary Team Processes in Lung Cancer Care: A Self-Assessment Toolkit and Best Practices

02/09/2024

Poka Cui

Peter Blanshard

María Teresa Campos-Partera

Adrien Moucquot

S. Hassan R. Naqvi

David Dellamonica

Heather Moses

Poka Cui and colleagues completed a literature review along with interviews involving lung cancer multidisciplinary teams from 24 medical centers across Europe and Canada. In this report, they also introduce a comprehensive self-assessment...

Poka Cui and colleagues...

02/09/2024

Journal of Clinical Pathways

News

Predicting Clinical Outcomes of Patients With High-Risk MCL

06/18/2020

Patients with high-risk mantle cell lymphoma (MCL) biology—defined by blastoid variance, Ki-67 greater than 30%, or high p53 immunohistochemistry expression—are more likely to experience shorter failure-free and...

...

06/18/2020

Journal of Clinical Pathways

News

NCCN Biomarker Guideline Adherence Linked With Decreased Mortality in NSCLC

06/16/2020

Adherence to the National Comprehensive Cancer Network (NCCN) guideline for biomarker testing for non-squamous advanced non-small cell lung cancer (NSCLC) is associated with decreased risk of mortality, according to a recent...

Adherence to the National...

06/16/2020

Journal of Clinical Pathways

Pharma Insights

Could the Lack of an Efficient and Affordable Diagnostic Pathway Limit Market Access for New Alzheimer`s Treatments?

06/20/2016

Rick Lifsitz, MBA

Larry Blandford, PharmD—Column Editor

The promise in the coming years of a novel therapeutic to slow the progression of the debilitating effects of Alzheimer’s disease (AD) is exciting and represents a monumental step forward in treating patients with...

The...

06/20/2016

Journal of Clinical Pathways

Research in Review

SERS Nanoprobes Help to Identify and Distinguish NSCLC Subtype

01/15/2016

JCP Editors

Chinese researchers have created an effective method for identifying and distinguishing non–small lung cancer (NSCLC) subtypes, utilizing nanotechnology in conjunction with statistical methods. The field of...

...

01/15/2016

Journal of Clinical Pathways